Back to search

Article

Feasability and effectiveness of scaling up hepatitis-C treatment in West and Central Africa: the TAC ANRS 12311 clinical trial

2023-11-28

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Access to direct-acting antivirals for chronic hepatitis C treatment in Sub-Saharan Africa is a clinical, public health and ethical concern. The multicenter open-label trial TAC ANRS 12311 was conducted to assess the feasibility, effectiveness and safety of an implementation model of HCV treatment and retreatment in patients with hepatitis C in Sub Saharan Africa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
74daede4-70a9-5e1d-8f75-a5c08881c393
DOI
10.21203/rs.3.rs-3577838/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Feasability and effectiveness of scaling up hepatitis-C treatment in West and Central Africa: the TAC ANRS 12311 clinical trialDOI 10.21203/rs.3.rs-3577838/v1
Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).Semantic proximity
Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030.Semantic proximity
Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.Semantic proximity
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.Semantic proximity
Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: long-term follow-up to assess feasibility and outcomes of a screening and treatment interventionSemantic proximity
Highly Diverse Hepatitis C Strains Detected in Sub‐Saharan Africa Have Unknown Susceptibility to Direct‐Acting Antiviral TreatmentsSemantic proximity
Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa.Semantic proximity
Hepatitis C treatment outcomes using interferon- and ribavirin-based therapy in Kigali, Rwanda.Semantic proximity
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.Semantic proximity
Evaluation of the survival of patients with cirrhosis of viral etiology B / C in 3 hospitals of Kinshasa in the Democratic Republic of CongoSemantic proximity
Mixed methods implementation research of oral antiviral treatment for COVID-19 in low and middle-income countries: a study protocolSemantic proximity
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).Semantic proximity
Select a neighboring publication to make it the new centre.